eBreCaP: extreme learning-based model for breast cancer survival prediction

Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review

Advancements in digital pathology and computing resources have made a significant impact in the field of computational pathology for breast cancer diagnosis and treatment. However, access to high-quality labeled histopathological images of breast cancer is a big challenge that limits the development of accurate and robust deep learning models. In this scoping review, we identified the publicly available datasets of breast H&E-stained whole-slide images (WSIs) that can be used to develop deep learning algorithms. We systematically searched 9 scientific literature databases and 9 research data repositories and found 17 publicly available datasets containing 10 385 H&E WSIs of breast cancer. Moreover, we reported image metadata and characteristics for each dataset to assist researchers in selecting proper datasets for specific tasks in breast cancer computational pathology. In addition, we compiled 2 lists of breast H&E patches and private datasets as supplementary resources for researchers. Notably, only 28% of the included articles utilized multiple datasets, and only 14% used an external validation set, suggesting that the performance of other developed models may be susceptible to overestimation. The TCGA-BRCA was used in 52% of the selected studies. This dataset has a considerable selection bias that can impact the robustness and generalizability of the trained algorithms. There is also a lack of consistent metadata reporting of breast WSI datasets that can be an issue in developing accurate deep learning models, indicating the necessity of establishing explicit guidelines for documenting breast WSI dataset characteristics and metadata.

Maintaining High-Touch in High-Tech Digital Health Monitoring and Multi-Omics Prognostication: Ethical, Equity, and Societal Considerations in Precision Health for Palliative Care

Advances in digital health, systems biology, environmental monitoring, and artificial intelligence (AI) continue to revolutionize health care, ushering a precision health future. More than disease treatment and prevention, precision health aims at maintaining good health throughout the lifespan. However, how can precision health impact care for people with a terminal or life-limiting condition? We examine here the ethical, equity, and societal/relational implications of two precision health modalities, (1) integrated systems biology/multi-omics analysis for disease prognostication and (2) digital health technologies for health status monitoring and communication. We focus on three main ethical and societal considerations: benefits and risks associated with integration of these modalities into the palliative care system; inclusion of underrepresented and marginalized groups in technology development and deployment; and the impact of high-tech modalities on palliative care's highly personalized and "high-touch" practice. We conclude with 10 recommendations for ensuring that precision health technologies, such as multi-omics prognostication and digital health monitoring, for palliative care are developed, tested, and implemented ethically, inclusively, and equitably.

FGCNSurv: dually fused graph convolutional network for multi-omics survival prediction

MOTIVATION

Survival analysis is an important tool for modeling time-to-event data, e.g. to predict the survival time of patient after a cancer diagnosis or a certain treatment. While deep neural networks work well in standard prediction tasks, it is still unclear how to best utilize these deep models in survival analysis due to the difficulty of modeling right censored data, especially for multi-omics data. Although existing methods have shown the advantage of multi-omics integration in survival prediction, it remains challenging to extract complementary information from different omics and improve the prediction accuracy.

RESULTS

In this work, we propose a novel multi-omics deep survival prediction approach by dually fused graph convolutional network (GCN) named FGCNSurv. Our FGCNSurv is a complete generative model from multi-omics data to survival outcome of patients, including feature fusion by a factorized bilinear model, graph fusion of multiple graphs, higher-level feature extraction by GCN and survival prediction by a Cox proportional hazard model. The factorized bilinear model enables to capture cross-omics features and quantify complex relations from multi-omics data. By fusing single-omics features and the cross-omics features, and simultaneously fusing multiple graphs from different omics, GCN with the generated dually fused graph could capture higher-level features for computing the survival loss in the Cox-PH model. Comprehensive experimental results on real-world datasets with gene expression and microRNA expression data show that the proposed FGCNSurv method outperforms existing survival prediction methods, and imply its ability to extract complementary information for survival prediction from multi-omics data.

AVAILABILITY AND IMPLEMENTATION

The codes are freely available at https://github.com/LiminLi-xjtu/FGCNSurv.

The research on TBATS and ELM models for prediction of human brucellosis cases in mainland China: a time series study

BACKGROUND

Human brucellosis is a serious public health concern in China. The objective of this study is to develop a suitable model for forecasting human brucellosis cases in mainland China.

METHODS

Data on monthly human brucellosis cases from January 2012 to December 2021 in 31 provinces and municipalities in mainland China were obtained from the National Health Commission of the People's Republic of China website. The TBATS and ELM models were constructed. The MAE, MSE, MAPE, and RMSE were calculated to evaluate the prediction performance of the two models.

RESULTS

The optimal TBATS model was TBATS (1, {0,0}, -, {< 12,4 >}) and the lowest AIC value was 1854.703. In the optimal TBATS model, {0,0} represents the ARIMA (0,0) model, {< 12,4 >} are the parameters of the seasonal periods and the corresponding number of Fourier terms, respectively, and the parameters of the Box-Cox transformation ω are 1. The optimal ELM model hidden layer number was 33 and the R-squared value was 0.89. The ELM model provided lower values of MAE, MSE, MAPE, and RMSE for both the fitting and forecasting performance.

CONCLUSIONS

The results suggest that the forecasting performance of ELM model outperforms the TBATS model in predicting human brucellosis between January 2012 and December 2021 in mainland China. Forecasts of the ELM model can help provide early warnings and more effective prevention and control measures for human brucellosis in mainland China.

Survival Risk Prediction of Esophageal Cancer Based on the Kohonen Network Clustering Algorithm and Kernel Extreme Learning Machine

Accurate prediction of the survival risk level of patients with esophageal cancer is significant for the selection of appropriate treatment methods. It contributes to improving the living quality and survival chance of patients. However, considering that the characteristics of blood index vary with individuals on the basis of their ages, personal habits and living environment etc., a unified artificial intelligence prediction model is not precisely adequate. In order to enhance the precision of the model on the prediction of esophageal cancer survival risk, this study proposes a different model based on the Kohonen network clustering algorithm and the kernel extreme learning machine (KELM), aiming to classifying the tested population into five catergories and provide better efficiency with the use of machine learning. Firstly, the Kohonen network clustering method was used to cluster the patient samples and five types of samples were obtained. Secondly, patients were divided into two risk levels based on 5-year net survival. Then, the Taylor formula was used to expand the theory to analyze the influence of different activation functions on the KELM modeling effect, and conduct experimental verification. RBF was selected as the activation function of the KELM. Finally, the adaptive mutation sparrow search algorithm (AMSSA) was used to optimize the model parameters. The experimental results were compared with the methods of the artificial bee colony optimized support vector machine (ABC-SVM), the three layers of random forest (TLRF), the gray relational analysis–particle swarm optimization support vector machine (GP-SVM) and the mixed-effects Cox model (Cox-LMM). The results showed that the prediction model proposed in this study had certain advantages in terms of prediction accuracy and running time, and could provide support for medical personnel to choose the treatment mode of esophageal cancer patients.

Software system to predict the infection in COVID-19 patients using deep learning and web of things

Since the end of 2019, computed tomography (CT) images have been used as an important substitute for the time-consuming Reverse Transcriptase polymerase chain reaction (RT-PCR) test; a new coronavirus 2019 (COVID-19) disease has been detected and has quickly spread through many countries across the world. Medical imaging such as computed tomography provides great potential due to growing skepticism toward the sensitivity of RT-PCR as a screening tool. For this purpose, automated image segmentation is highly desired for a clinical decision aid and disease monitoring. However, there is limited publicly accessible COVID-19 image knowledge, leading to the overfitting of conventional approaches. To address this issue, the present paper focuses on data augmentation techniques to create synthetic data. Further, a framework has been proposed using WoT and traditional U-Net with EfficientNet B0 to segment the COVID Radiopedia and Medseg datasets automatically. The framework achieves an F-score of 0.96, which is best among state-of-the-art methods. The performance of the proposed framework also computed using Sensitivity, Specificity, and Dice-coefficient, achieves 84.5%, 93.9%, and 65.0%, respectively. Finally, the proposed work is validated using three quality of service (QoS) parameters such as server latency, response time, and network latency which improves the performance by 8%, 7%, and 10%, respectively.

OUP accepted manuscript

Motivation

Cancer survival prediction can greatly assist clinicians in planning patient treatments and improving their life quality. Recent evidence suggests the fusion of multimodal data, such as genomic data and pathological images, is crucial for understanding cancer heterogeneity and enhancing survival prediction. As a powerful multimodal fusion technique, Kronecker product has shown its superiority in predicting survival. However, this technique introduces a large number of parameters that may lead to high computational cost and a risk of overfitting, thus limiting its applicability and improvement in performance. Another limitation of existing approaches using Kronecker product is that they only mine relations for one single time to learn multimodal representation and therefore face significant challenges in deeply mining rich information from multimodal data for accurate survival prediction.

Results

To address the above limitations, we present a novel hierarchical multimodal fusion approach named HFBSurv by employing factorized bilinear model to fuse genomic and image features step by step. Specifically, with a multiple fusion strategy HFBSurv decomposes the fusion problem into different levels and each of them integrates and passes information progressively from the low level to the high level, thus leading to the more specialized fusion procedure and expressive multimodal representation. In this hierarchical framework, both modality-specific and cross-modality attentional factorized bilinear modules are designed to not only capture and quantify complex relations from multimodal data, but also dramatically reduce computational complexity. Extensive experiments demonstrate that our method performs an effective hierarchical fusion of multimodal data and achieves consistently better performance than other methods for survival prediction.

Availability and implementation

HFBSurv is freely available at https://github.com/Liruiqing-ustc/HFBSurv.

Supplementary information

Supplementary data are available at Bioinformatics online.

Optimal control methods for drug delivery in cancerous tumour by anti-angiogenic therapy and chemotherapy

There are numerous mathematical models simulating the behaviour of cancer by considering variety of states in different treatment strategies, such as chemotherapy. Among the models, one is developed which is able to consider the blood vessel‐production (angiogenesis) in the vicinity of the tumour and the effect of anti‐angiogenic therapy. In the mentioned‐model, normal cells, cancer cells, endothelial cells, chemotherapy and anti‐angiogenic agents are taking into account as state variables, and the rate of injection of the last two are considered as control inputs. Since controlling the cancerous tumour growth is a challenging matter for patient's life, the time schedule design of drug injection is very significant. Two optimal control strategies, an open‐loop (calculus of variations) and a closed‐loop (state‐dependent Riccati equation), are applied on the system in order to find an optimal time scheduling for each drug injection. By defining a proper cost function, an optimal control signal is designed for each one. Both obtained control inputs have reasonable answers, and the system is controlled eventually, but by comparing them, it is concluded that both methods have their own benefits which will be discussed in details in the conclusion section.